OS Therapies Incorporated

US$1.00As of Sun 8 Nov 2026, 12:00 UTC
AMEX:OSTXHealthcare
Country USA
PE (Fwd) •••
TSR 2Y CAGR (47.77%)
Div yield —
ROE —
Biotechnology
Beta (5Y) (0.48)
PE TTM —
TSR TTM (46.24%)
Mkt cap US$46.21M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.11
11.40%
(32.40%)
Hold 6|3|8|6|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.02
0.03
0.03
27.87%
10.15%
11.87%
22.85%
Revenue$M
2.689
2.786
2.759
2.749
13.08%
16.67%
12.79%
7.49%
Peers (US$46.21M)
Cap (US$)
PE
46.60M
—
46.32M
—
Capital
TTM
5Y
10Y
Leveragex
0.449
(0.125)
(0.113)
EBIT/Intx
0.616
0.094
0.117
Own earn%
9.79
(25.20)
(26.93)
Sh yield%
41.30
40.09
39.25
Owners
Insiders/Inst%
11.42
82.85
Short interest%
1.46
SBC / revenue%
0.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
17–24
$1 testx
−0.3
Incr. ROIC%
0